nach oben

Die Urologie

Erschienen in:

29.04.2023 | Schmerzsyndrome | Leitthema

Chronische Prostatitis/chronisches Beckenschmerzsyndrom

verfasst von: PD. Dr. med. G. Magistro, F. M. E. Wagenlehner, A. Pilatz

Erschienen in: Die Urologie | Ausgabe 6/2023

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die chronische Prostatitis/chronisches Beckenschmerzsyndrom (CP/CPPS) ist definiert als chronischer Schmerz oder Missempfindung im Beckenbereich für mindestens 3 Monate im letzten Halbjahr und weist eine häufige Assoziation mit Miktionsbeschwerden, psychosozialen Störungen und sexueller Dysfunktion auf. Weder Biomarker noch spezifische Testverfahren stehen für die eindeutige Diagnosestellung zur Verfügung. Die Basisdiagnostik bildet differenziert das individuelle Beschwerdebild des Patienten ab und schließt potenzielle Differentialdiagnosen für Beckenschmerzen aus. „Patient-reported outcome measures“ (PROMs) wie der Chronic Prostatitis Symptom Index (CPSI) sind validierte Instrumente zur objektiven Erfassung der Symptomatik und eignen sich für das initiale Assessment und weitere Therapiemonitoring. Das UPOINTS-Schema („urinary, psychosocial, organ specific, infection, neurologic/systemic, tenderness, sexual dysfunction“) bildet das individuelle Beschwerdebild der Patienten ab, weist den weiteren Weg der diagnostischen Abklärung auf und bestimmt das multimodale und personalisierte Therapiekonzept. Eine engmaschige urologische Begleitung der CP/CPPS-Patienten ist in der Regel notwendig, um insbesondere den unreflektierten Einsatz von Antibiotika bei wellenförmigen Beschwerden zu minimieren.

McNaughton Collins M, Pontari MA, O’Leary MP, Calhoun EA, Santanna J, Landis JR et al (2001) Quality of life is impaired in men with chronic prostatitis: the chronic prostatitis collaborative research network. J Gen Intern Med 16(10):656–662PubMedPubMedCentralCrossRef

Krieger JN, Lee SW, Jeon J, Cheah PY, Liong ML, Riley DE (2008) Epidemiology of prostatitis. Int J Antimicrob Agents 31(1):S85–90PubMedCrossRef

Collins MM, Stafford RS, O’Leary MP, Barry MJ (1998) How common is prostatitis? A national survey of physician visits. J Urol 159(4):1224–1228PubMedCrossRef

Nickel JC, Tripp DA, Chuai S, Litwin MS, McNaughton-Collins M, Landis JR et al (2008) Psychosocial variables affect the quality of life of men diagnosed with chronic prostatitis/chronic pelvic pain syndrome. BJU Int 101(1):59–64PubMed

Krieger JN, Nyberg L Jr, Nickel JC (1999) NIH consensus definition and classification of prostatitis. JAMA 282(3):236–237PubMedCrossRef

Yoon BI, Kim S, Han DS, Ha US, Lee SJ, Kim HW et al (2012) Acute bacterial prostatitis: how to prevent and manage chronic infection? J Infect Chemother 18(4):444–450PubMedCrossRef

Bartoletti R, Cai T, Mondaini N, Dinelli N, Pinzi N, Pavone C et al (2007) Prevalence, incidence estimation, risk factors and characterization of chronic prostatitis/chronic pelvic pain syndrome in urological hospital outpatients in Italy: results of a multicenter case-control observational study. J Urol 178(6):2411–2415 (discussion 2415)PubMedCrossRef

de la Rosette JJ, Hubregtse MR, Meuleman EJ, Stolk-Engelaar MV, Debruyne FM (1993) Diagnosis and treatment of 409 patients with prostatitis syndromes. Urology 41(4):301–307PubMedCrossRef

Litwin MS, McNaughton-Collins M, Fowler FJ Jr, Nickel JC, Calhoun EA, Pontari MA et al (1999) The national institutes of health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic prostatitis collaborative research network. J Urol 162(2):369–375PubMedCrossRef

10.

Zermann DH, Ishigooka M, Doggweiler R, Schmidt RA (1999) Neurourological insights into the etiology of genitourinary pain in men. J Urol 161(3):903–908PubMedCrossRef

11.

Wagenlehner FM, van Till JW, Magri V, Perletti G, Houbiers JG, Weidner W et al (2013) National Institutes of Health chronic prostatitis symptom index (NIH-CPSI) symptom evaluation in multinational cohorts of patients with chronic prostatitis/chronic pelvic pain syndrome. Eur Urol 63(5):953–959PubMedCrossRef

12.

Shoskes DA, Landis JR, Wang Y, Nickel JC, Zeitlin SI, Nadler R et al (2004) Impact of post-ejaculatory pain in men with category III chronic prostatitis/chronic pelvic pain syndrome. J Urol 172(2):542–547PubMedCrossRef

13.

Samplaski MK, Li J, Shoskes DA (2012) Clustering of UPOINT domains and subdomains in men with chronic prostatitis/chronic pelvic pain syndrome and contribution to symptom severity. J Urol 188(5):1788–1793PubMedCrossRef

14.

Shoskes DA, Nickel JC, Dolinga R, Prots D (2009) Clinical phenotyping of patients with chronic prostatitis/chronic pelvic pain syndrome and correlation with symptom severity. Urology 73(3):538–542 (discussion 542–543)PubMedCrossRef

15.

Shoskes DA, Nickel JC, Kattan MW (2010) Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT. Urology 75(6):1249–1253PubMedCrossRef

16.

Beutel ME, Weidner W, Brahler E (2004) Chronic pelvic pain and its comorbidity. Urologe A 43(3):261–267PubMedCrossRef

17.

Lee SW, Liong ML, Yuen KH, Leong WS, Cheah PY, Khan NA et al (2008) Adverse impact of sexual dysfunction in chronic prostatitis/chronic pelvic pain syndrome. Urology 71(1):79–84PubMedCrossRef

18.

Liang CZ, Hao ZY, Li HJ, Wang ZP, Xing JP, Hu WL et al (2010) Prevalence of premature ejaculation and its correlation with chronic prostatitis in Chinese men. Urology 76(4):962–966PubMedCrossRef

19.

Liang CZ, Zhang XJ, Hao ZY, Shi HQ, Wang KX (2004) Prevalence of sexual dysfunction in Chinese men with chronic prostatitis. BJU Int 93(4):568–570PubMedCrossRef

20.

Magri V, Perletti G, Montanari E, Marras E, Chiaffarino F, Parazzini F (2008) Chronic prostatitis and erectile dysfunction: results from a cross-sectional study. Arch Ital Urol Androl 80(4):172–175PubMed

21.

Mehik A, Hellström P, Sarpola A, Lukkarinen O, Järvelin MR (2001) Fears, sexual disturbances and personality features in men with prostatitis: a population-based cross-sectional study in Finland. BJU Int 88(1):35–38PubMedCrossRef

22.

Trinchieri A, Magri V, Cariani L, Bonamore R, Restelli A, Garlaschi MC et al (2007) Prevalence of sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome. Arch Ital Urol Androl 79(2):67–70PubMed

23.

Zhang Y, Zheng T, Tu X, Chen X, Wang Z, Chen S et al (2016) Erectile dysfunction in chronic prostatitis/chronic pelvic pain syndrome: outcomes from a multi-center study and risk factor analysis in a single center. PLoS One 11(4):e153054PubMedPubMedCentralCrossRef

24.

Egan KJ, Krieger JN (1994) Psychological problems in chronic prostatitis patients with pain. Clin J Pain 10(3):218–226PubMedCrossRef

25.

Ku JH, Kim SW, Paick JS (2005) Quality of life and psychological factors in chronic prostatitis/chronic pelvic pain syndrome. Urology 66(4):693–701PubMedCrossRef

26.

Clemens JQ, Brown SO, Kozloff L, Calhoun EA (2006) Predictors of symptom severity in patients with chronic prostatitis and interstitial cystitis. J Urol 175(3 Pt 1):963–966 (discussion 967)PubMedCrossRef

27.

Pontari MA (2006) Chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: are they related? Curr Urol Rep 7(4):329–334PubMedCrossRef

28.

Vicari E, La Vignera S, Arcoria D, Condorelli R, Vicari LO, Castiglione R et al (2011) High frequency of chronic bacterial and non-inflammatory prostatitis in infertile patients with prostatitis syndrome plus irritable bowel syndrome. PLoS One 6(4):e18647PubMedPubMedCentralCrossRef

29.

Propert KJ, McNaughton-Collins M, Leiby BE, O’Leary MP, Kusek JW, Litwin MS et al (2006) A prospective study of symptoms and quality of life in men with chronic prostatitis/chronic pelvic pain syndrome: the national institutes of health chronic prostatitis cohort study. J Urol 175(2):619–623 (discussion 623)PubMedCrossRef

30.

Tripp DA, Nickel CJ, Landis JR, Wang YL, Knauss JS, Group CS. (2004) Predictors of quality of life and pain in chronic prostatitis/chronic pelvic pain syndrome: findings from the national institutes of health chronic prostatitis cohort study. BJU Int 94(9):1279–1282PubMedCrossRef

31.

Propert KJ, Litwin MS, Wang Y, Alexander RB, Calhoun E, Nickel JC et al (2006) Responsiveness of the national institutes of health chronic prostatitis symptom index (NIH-CPSI). Qual Life Res 15(2):299–305PubMedCrossRef

32.

Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A (1997) The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49(6):822–830PubMedCrossRef

33.

Cappelleri JC, Rosen RC (2005) The sexual health inventory for men (SHIM): a 5-year review of research and clinical experience. Int J Impot Res 17(4):307–319PubMedCrossRef

34.

Rees J, Abrahams M, Doble A, Cooper A, Prostatitis Expert Reference Group (PERG) (2015) Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline. BJU Int 116(4):509–525PubMedPubMedCentralCrossRef

35.

Meares EM, Stamey TA (1968) Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol 5(5):492–518PubMed

36.

Nickel JC, Shoskes D, Wang Y, Alexander RB, Fowler JE Jr, Zeitlin S et al (2006) How does the pre-massage and post-massage 2‑glass test compare to the Meares-Stamey 4‑glass test in men with chronic prostatitis/chronic pelvic pain syndrome? J Urol 176(1):119–124PubMedCrossRef

37.

Davis SN, Binik YM, Amsel R, Carrier S (2013) Is a sexual dysfunction domain important for quality of life in men with urological chronic pelvic pain syndrome? Signs “UPOINT” to yes. J Urol 189(1):146–151PubMedCrossRef

38.

Magri V, Wagenlehner F, Perletti G, Schneider S, Marras E, Naber KG et al (2010) Use of the UPOINT chronic prostatitis/chronic pelvic pain syndrome classification in European patient cohorts: sexual function domain improves correlations. J Urol 184(6):2339–2345PubMedCrossRef

39.

Nickel JC, Shoskes D (2009) Phenotypic approach to the management of chronic prostatitis/chronic pelvic pain syndrome. Curr Urol Rep 10(4):307–312PubMedCrossRef

40.

Shoskes DA, Nickel JC (2013) Classification and treatment of men with chronic prostatitis/chronic pelvic pain syndrome using the UPOINT system. World J Urol 31(4):755–760PubMedCrossRef

41.

Shoskes DA, Nickel JC, Rackley RR, Pontari MA (2009) Clinical phenotyping in chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: a management strategy for urologic chronic pelvic pain syndromes. Prostate Cancer Prostatic Dis 12(2):177–183PubMedCrossRef

42.

Magistro G, Wagenlehner FM, Grabe M, Weidner W, Stief CG, Nickel JC (2016) Contemporary management of chronic prostatitis/chronic pelvic pain syndrome. Eur Urol 69(2):286–297. https://doi.org/10.1016/j.eururo.2015.08.061CrossRefPubMed

43.

Schagdarsurengin U, Teuchert LM, Hagenkötter C, Nesheim N, Dansranjavin T, Schuppe HC et al (2017) Chronic prostatitis affects male reproductive health and is associated with systemic and local epigenetic inactivation of C‑X‑C motif chemokine 12 receptor C‑X‑C chemokine receptor type 4. Urol Int 98(1):89–101PubMedCrossRef

44.

Nesheim N, Ellem S, Dansranjavin T, Hagenkötter C, Berg E, Schambeck R et al (2018) Elevated seminal plasma estradiol and epigenetic inactivation of ESR1 and ESR2 is associated with CP/CPPS. Oncotarget 9(28):19623–19639PubMedPubMedCentralCrossRef

45.

Anothaisintawee T, Attia J, Nickel JC, Thammakraisorn S, Numthavaj P, McEvoy M et al (2011) Management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and network meta-analysis. JAMA 305(1):78–86PubMedCrossRef

46.

Cohen JM, Fagin AP, Hariton E, Niska JR, Pierce MW, Kuriyama A et al (2012) Therapeutic intervention for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a systematic review and meta-analysis. PLoS One 7(8):e41941PubMedPubMedCentralCrossRef

47.

Franco JV, Turk T, Jung JH, Xiao YT, Iakhno S, Garrote V et al (2018) Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome. Cochrane Database Syst Rev 5:CD12551PubMed

48.

Franco JVA, Turk T, Jung JH, Xiao YT, Iakhno S, Tirapegui FI et al (2020) Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome: a Cochrane systematic review. BJU Int 125(4):490–496. https://doi.org/10.1111/bju.14988CrossRefPubMed

49.

Falahatkar S, Shahab E, Gholamjani Moghaddam K, Kazemnezhad E (2015) Transurethral intraprostatic injection of botulinum neurotoxin type A for the treatment of chronic prostatitis/chronic pelvic pain syndrome: results of a prospective pilot double-blind and randomized placebo-controlled study. BJU Int 116(4):641–649PubMedCrossRef

50.

Guan X, Zhao C, Ou ZY, Wang L, Zeng F, Qi L et al (2015) Use of the UPOINT phenotype system in treating Chinese patients with chronic prostatitis/chronic pelvic pain syndrome: a prospective study. Asian J Androl 17(1):120–123PubMedCrossRef

51.

Magri V, Marras E, Restelli A, Wagenlehner FM, Perletti G (2015) Multimodal therapy for category III chronic prostatitis/chronic pelvic pain syndrome in UPOINTS phenotyped patients. Exp Ther Med 9(3):658–666PubMedCrossRef

52.

Magistro G, Stief CG, Wagenlehner FME (2020) Chronic prostatitis/chronic pelvic pain syndrome. Urologe A 59(6):739–748PubMedCrossRef

Titel: Chronische Prostatitis/chronisches Beckenschmerzsyndrom
verfasst von: PD. Dr. med. G. Magistro
F. M. E. Wagenlehner
A. Pilatz
Publikationsdatum: 29.04.2023
Verlag: Springer Medizin
Schlagwörter: Schmerzsyndrome
Spezielle urologische Diagnostik
Harnwegsinfektionen in der Urologie
Erektile Dysfunktion
Prostatitis
Blasenentleerungsstörungen
Harnwegsinfektionen
Allgemeine Diagnostik
Erschienen in: Die Urologie / Ausgabe 6/2023
Print ISSN: 2731-7064
Elektronische ISSN: 2731-7072
DOI: https://doi.org/10.1007/s00120-023-02089-2

Passend zum Thema

Phytotherapie bei CPPS

Pollstimol®: Leitliniengerechte Prostatitis-Therapie

In 90 % der Prostatitis-Fälle handelt es sich um eine chronische abakterielle Prostatitis (chronic pelvic pain syndrome, CPPS) mit anhaltender Entzündungsreaktion und Schwellung der Prostata. Als leitliniengerechte Behandlungsoption mit guter Evidenz hat sich das Phytotherapeutikum Pollstimol® etabliert.

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2023

Berufspolitik BvDU

Zarte Hände bringen Erleichterung. Thure-Brandt-Massage als Zeitdokument und Gründungshilfe für die Urologie

10 Gebote für gelingende Kommunikation in der Schmerzmedizin

Soll die asymptomatische Bakteriurie bei Immunsupprimierten antibiotisch therapiert werden?

Die digitale Zukunft der Gesundheitsversorgung

Mitteilungen der DGU

Passend zum Thema

Pollstimol®: Leitliniengerechte Prostatitis-Therapie